PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 83 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $356,000 | +21.1% | 68,940 | -10.1% | 0.00% | – |
| Q2 2021 | $294,000 | +40.7% | 76,683 | -5.9% | 0.00% | – |
| Q1 2021 | $209,000 | -7.9% | 81,471 | -10.5% | 0.00% | – |
| Q4 2020 | $227,000 | +39.3% | 90,995 | +15.2% | 0.00% | – |
| Q3 2020 | $163,000 | -35.6% | 78,967 | -3.3% | 0.00% | – |
| Q2 2020 | $253,000 | +44.6% | 81,702 | +6.5% | 0.00% | – |
| Q1 2020 | $175,000 | +173.4% | 76,741 | +304.1% | 0.00% | – |
| Q3 2019 | $64,000 | +52.4% | 18,989 | +49.5% | 0.00% | – |
| Q1 2019 | $42,000 | -39.1% | 12,701 | -7.2% | 0.00% | – |
| Q2 2018 | $69,000 | -34.9% | 13,687 | -12.2% | 0.00% | – |
| Q1 2018 | $106,000 | +37.7% | 15,585 | +53.1% | 0.00% | – |
| Q4 2017 | $77,000 | -42.1% | 10,181 | -56.0% | 0.00% | – |
| Q3 2017 | $133,000 | +146.3% | 23,140 | +120.5% | 0.00% | – |
| Q2 2017 | $54,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
| BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
| Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
| Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
| EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
| Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
| EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
| Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |